These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

958 related articles for article (PubMed ID: 31939254)

  • 1. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients.
    Karami-Zarandi M; Bahador A; Gizaw Feysia S; Kardan-Yamchi J; Hasan-Nejad M; Mosavari N; Feizabadi MM
    Arch Razi Inst; 2019 Dec; 74(4):375-384. PubMed ID: 31939254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and risk factors associated with NTM pulmonary and extrapulmonary infections in a high tuberculosis endemic Region.
    Wani SR; Wattal C; Raveendran R
    Indian J Med Microbiol; 2020; 38(2):169-175. PubMed ID: 32883930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-tuberculous mycobacteria profiles and their anti-mycobacterial resistance at a major medical center in Lebanon.
    Araj GF; Baba OZ; Itani LY; Avedissian AZ; Sobh GM
    J Infect Dev Ctries; 2019 Jul; 13(7):612-618. PubMed ID: 32065818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Clinical Manifestation, Treatment Outcome, and Drug Susceptibility Pattern of Nontuberculous Mycobacteria in HIV Patients in Tehran, Iran.
    Feysia SG; Hasan-Nejad M; Amini S; Hamzelou G; Kazemian H; Kardan-Yamchi J; Karami-Zarandi M; Feizabadi MM
    Ethiop J Health Sci; 2020 Jan; 30(1):75-84. PubMed ID: 32116435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and species spectrum of both pulmonary and extrapulmonary nontuberculous mycobacteria isolates at a tertiary care center.
    Umrao J; Singh D; Zia A; Saxena S; Sarsaiya S; Singh S; Khatoon J; Dhole TN
    Int J Mycobacteriol; 2016 Sep; 5(3):288-293. PubMed ID: 27847012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug susceptibility of rapid and slow growing non-tuberculous mycobacteria isolated from symptomatics for pulmonary tuberculosis, Central India.
    Goswami B; Narang P; Mishra PS; Narang R; Narang U; Mendiratta DK
    Indian J Med Microbiol; 2016; 34(4):442-447. PubMed ID: 27934821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real time PCR for the rapid identification and drug susceptibility of Mycobacteria present in Bronchial washings.
    Keerthirathne TP; Magana-Arachchi DN; Madegedara D; Sooriyapathirana SS
    BMC Infect Dis; 2016 Oct; 16(1):607. PubMed ID: 27782812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and speciation of non-tuberculous mycobacteria among pulmonary and extrapulmonary tuberculosis suspects in South India.
    Thangavelu K; Krishnakumariamma K; Pallam G; Dharm Prakash D; Chandrashekar L; Kalaiarasan E; Das S; Muthuraj M; Joseph NM
    J Infect Public Health; 2021 Mar; 14(3):320-323. PubMed ID: 33618276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana.
    Addo KK; Addo SO; Mensah GI; Mosi L; Bonsu FA
    BMC Infect Dis; 2017 Dec; 17(1):743. PubMed ID: 29197331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey].
    Ceyhan İ; Özkara Ş; Güler MZ; Dulkar G; Altınsoy R; Vezir S
    Mikrobiyol Bul; 2019 Jul; 53(3):330-335. PubMed ID: 31414634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the distribution of non-tuberculous mycobacteria strains isolated in National Tuberculosis Reference Laboratory in 2009-2010, Turkey].
    Albayrak N; Simşek H; Sezen F; Arslantürk A; Tarhan G; Ceyhan I
    Mikrobiyol Bul; 2012 Oct; 46(4):560-7. PubMed ID: 23188570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
    Hershko Y; Adler A
    Microb Drug Resist; 2023 Jul; 29(7):302-308. PubMed ID: 37219996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in nontuberculous mycobacteria isolated in Shanghai, China: results from a population-based study.
    Wu J; Zhang Y; Li J; Lin S; Wang L; Jiang Y; Pan Q; Shen X
    PLoS One; 2014; 9(10):e109736. PubMed ID: 25330201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimicrobial susceptibility of non-tuberculous mycobacteria.
    Cowman S; Burns K; Benson S; Wilson R; Loebinger MR
    J Infect; 2016 Mar; 72(3):324-31. PubMed ID: 26723913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G; Wu L; Zheng Q; Jiang X
    Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran.
    Daneshfar S; Khosravi AD; Hashemzadeh M
    PLoS One; 2022; 17(8):e0267320. PubMed ID: 35960778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.